Global Meropenem Market Professional Survey Report 2016
- QYR585264
- 157 Pages
- May 2016
- Pharmaceuticals
Mainly covers the following product types
Injection
Freeze-dried powder
The segment applications including
Hospital use
Clinic
Others
Segment regions including (the separated region report can also be offered)
USA
China
UK
France
Switzerland
Japan
Germany
The players list (Partly, Players you are interested in can also be added)
Pfizer
Shenzhen Haibin Pharmaceutical
Novartis
Mylan
GE Healthcare
Spectrum Chemical Manufacturing Corp
Abbott
Takeda
Hisun-Pfizer Pharmaceuticals
Haikou Pharmaceutical Factory
Shijiazhuang Pharma
Sumitomo Pharmaceuticals
Sumitomo Dainippon Pharma Co.,Ltd
Varika Chemicals & Pharmaceuticals Ltd
Astra Zeneca Pharma India Limited
Crucell Switzerland AG
With no less than 15 top producers.
Data including (both global and regions): Market Size (both volume - Bottle and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Bottle, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Meropenem
1.1 Definition and Specifications of Meropenem
1.1.1 Definition of Meropenem
1.1.2 Specifications of Meropenem
1.1.2.1 0.25g/Bottle
1.1.2.2 0.5g/Bottle
1.2 Classification of Meropenem
1.2.1 Injection
1.2.2 Freeze-dried powder
1.3 Applications of Meropenem
1.3.1 Hospital use
1.3.2 Clinic
1.3.3 Others
1.4 Industry Chain Structure of Meropenem
1.5 Industry Overview and Major Regions Status of Meropenem
1.5.1 Industry Overview of Meropenem
1.5.2 Global Major Regions Status of Meropenem
1.6 Industry Policy Analysis of Meropenem
1.7 Industry News Analysis of Meropenem
2 Manufacturing Cost Structure Analysis of Meropenem
2.1 Raw Material Suppliers and Price Analysis of Meropenem
2.2 Equipment Suppliers and Price Analysis of Meropenem
2.3 Labor Cost Analysis of Meropenem
2.4 Other Costs Analysis of Meropenem
2.5 Manufacturing Cost Structure Analysis of Meropenem
2.6 Manufacturing Process Analysis of Meropenem
3 Technical Data and Manufacturing Plants Analysis of Meropenem
3.1 Capacity and Commercial Production Date of Global Meropenem Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Meropenem Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Meropenem Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Meropenem Major Manufacturers in 2015
4 Global Meropenem Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Meropenem Capacity and Growth Rate Analysis
4.2.2 2015 Meropenem Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Meropenem Sales and Growth Rate Analysis
4.3.2 2015 Meropenem Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Meropenem Sales Price
4.4.2 2015 Meropenem Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Meropenem Gross Margin
4.5.2 2015 Meropenem Gross Margin Analysis (Company Segment)
5 Meropenem Regional Market Analysis
5.1 USA Meropenem Market Analysis
5.1.1 USA Meropenem Market Overview
5.1.2 USA 2011-2016E Meropenem Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E Meropenem Sales Price Analysis
5.1.4 USA 2015 Meropenem Market Share Analysis
5.2 China Meropenem Market Analysis
5.2.1 China Meropenem Market Overview
5.2.2 China 2011-2016E Meropenem Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Meropenem Sales Price Analysis
5.2.4 China 2015 Meropenem Market Share Analysis
5.3 UK Meropenem Market Analysis
5.3.1 UK Meropenem Market Overview
5.3.2 UK 2011-2016E Meropenem Local Supply, Import, Export, Local Consumption Analysis
5.3.3 UK 2011-2016E Meropenem Sales Price Analysis
5.3.4 UK 2015 Meropenem Market Share Analysis
5.4 France Meropenem Market Analysis
5.4.1 France Meropenem Market Overview
5.4.2 France 2011-2016E Meropenem Local Supply, Import, Export, Local Consumption Analysis
5.4.3 France 2011-2016E Meropenem Sales Price Analysis
5.4.4 France 2015 Meropenem Market Share Analysis
5.5 Switzerland Meropenem Market Analysis
5.5.1 Switzerland Meropenem Market Overview
5.5.2 Switzerland 2011-2016E Meropenem Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Switzerland 2011-2016E Meropenem Sales Price Analysis
5.5.4 Switzerland 2015 Meropenem Market Share Analysis
5.6 Japan Meropenem Market Analysis
5.6.1 Japan Meropenem Market Overview
5.6.2 Japan 2011-2016E Meropenem Local Supply, Import, Export, Local Consumption Analysis
5.6.3 Japan 2011-2016E Meropenem Sales Price Analysis
5.6.4 Japan 2015 Meropenem Market Share Analysis
5.7 Germany Meropenem Market Analysis
5.7.1 Germany Meropenem Market Overview
5.7.2 Germany 2011-2016E Meropenem Local Supply, Import, Export, Local Consumption Analysis
5.7.3 Germany 2011-2016E Meropenem Sales Price Analysis
5.7.4 Germany 2015 Meropenem Market Share Analysis
6 Global 2011-2016E Meropenem Segment Market Analysis (by Type)
6.1 Global 2011-2016E Meropenem Sales by Type
6.2 Different Types Meropenem Product Interview Price Analysis
6.3 Different Types Meropenem Product Driving Factors Analysis
6.3.1 Injection Meropenem Growth Driving Factor Analysis
6.3.2 Freeze-dried powder Meropenem Growth Driving Factor Analysis
7 Global 2011-2016E Meropenem Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital use Meropenem Growth Driving Factor Analysis
7.3.2 Clinic Meropenem Growth Driving Factor Analysis
7.3.3 Others Meropenem Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Meropenem
8.1 Pfizer
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Pfizer 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Pfizer 2015 Meropenem Business Region Distribution Analysis
8.3 Shenzhen Haibin Pharmaceutical
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Shenzhen Haibin Pharmaceutical 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Shenzhen Haibin Pharmaceutical 2015 Meropenem Business Region Distribution Analysis
8.4 Novartis
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Novartis 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Novartis 2015 Meropenem Business Region Distribution Analysis
8.5 Mylan
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Mylan 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Mylan 2015 Meropenem Business Region Distribution Analysis
8.8 GE Healthcare
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 GE Healthcare 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 GE Healthcare 2015 Meropenem Business Region Distribution Analysis
8.11 Spectrum Chemical Manufacturing Corp
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Spectrum Chemical Manufacturing Corp 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Spectrum Chemical Manufacturing Corp 2015 Meropenem Business Region Distribution Analysis
8.12 Abbott
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Abbott 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Abbott 2015 Meropenem Business Region Distribution Analysis
8.13 Takeda
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Takeda 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Takeda 2015 Meropenem Business Region Distribution Analysis
8.14 Hisun-Pfizer Pharmaceuticals
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Hisun-Pfizer Pharmaceuticals 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Hisun-Pfizer Pharmaceuticals 2015 Meropenem Business Region Distribution Analysis
8.15 Haikou Pharmaceutical Factory
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Haikou Pharmaceutical Factory 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Haikou Pharmaceutical Factory 2015 Meropenem Business Region Distribution Analysis
8.16 Shijiazhuang Pharma
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Shijiazhuang Pharma 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Shijiazhuang Pharma 2015 Meropenem Business Region Distribution Analysis
Sumitomo Pharmaceuticals
.1 Company Profile
.2 Product Picture and Specifications
.3 Sumitomo Pharmaceuticals 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
.4 Sumitomo Pharmaceuticals 2015 Meropenem Business Region Distribution Analysis
Sumitomo Dainippon Pharma Co.,Ltd
.1 Company Profile
.2 Product Picture and Specifications
.3 Sumitomo Dainippon Pharma Co.,Ltd 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
.4 Sumitomo Dainippon Pharma Co.,Ltd 2015 Meropenem Business Region Distribution Analysis
Varika Chemicals & Pharmaceuticals Ltd
.1 Company Profile
.2 Product Picture and Specifications
.3 Varika Chemicals & Pharmaceuticals Ltd 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
.4 Varika Chemicals & Pharmaceuticals Ltd 2015 Meropenem Business Region Distribution Analysis
Astra Zeneca Pharma India Limited
.1 Company Profile
.2 Product Picture and Specifications
.3 Astra Zeneca Pharma India Limited 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
.4 Astra Zeneca Pharma India Limited 2015 Meropenem Business Region Distribution Analysis
Crucell Switzerland AG
.1 Company Profile
.2 Product Picture and Specifications
.3 Crucell Switzerland AG 2015 Meropenem Sales, Ex-factory Price, Revenue, Gross Margin Analysis
.4 Crucell Switzerland AG 2015 Meropenem Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 Meropenem Consumption Forecast
9.2.2 China 2016-2021 Meropenem Consumption Forecast
9.2.3 UK 2016-2021 Meropenem Consumption Forecast
9.2.4 France 2016-2021 Meropenem Consumption Forecast
9.2.5 Switzerland 2016-2021 Meropenem Consumption Forecast
9.2.6 Japan 2016-2021 Meropenem Consumption Forecast
9.2.7 Germany 2016-2021 Meropenem Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Meropenem Marketing Model Analysis
10.1 Meropenem Regional Marketing Model Analysis
10.2 Meropenem International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Meropenem by Regions
10.4 Meropenem Supply Chain Analysis
11 Consumers Analysis of Meropenem
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Meropenem
12.1 New Project SWOT Analysis of Meropenem
12.2 New Project Investment Feasibility Analysis of Meropenem
13 Conclusion of the Global Meropenem Market Professional Survey Report 2016
N/A
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
